» Articles » PMID: 26536600

Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease

Overview
Journal PLoS One
Date 2015 Nov 5
PMID 26536600
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To search for biomarkers to differentiate primary focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).

Methods: We isolated glomeruli from kidney biopsies of 6 patients with adult-onset steroid sensitiveFSGS and 5 patients with MCD, and compared the profiles of glomerular transcriptomes between the two groups of patients using microarray analysis.

Results: Analysis of differential expressed genes (DEGs) revealed that up-regulated DEGs in FSGS patients compared with MCD patients were primarily involved in spermatogenesis, gamete generation, regulation of muscle contraction, response to unfolded protein, cell proliferation and skeletal system development. The down-regulated DEGs were primarily related to metabolic process, intracellular transport, oxidation/reduction andestablishment of intracellular localization. We validated the expression of the top 6 up-regulated and top 6 down-regulated DEGs using real-time PCR. Membrane metallo-endopeptidase (MME) is a down-regulated gene that was previously identified as a key gene for kidney development. Immunostaining confirmed that the protein expression of MME decreased significantly in FSGS kidneys compared with MCD kidneys.

Conclusions: This report was the first study to examine transcriptomes in Chinese patients with various glomerular diseases. Expressions of MME both in RNA and protein level decreased significantly in glomeruli of FSGS kidneys compared with MCD kidneys. Our data suggested that MME might play a role in the normal physiological function of podocytes and a decrease in MME expression might be related to podocyte injury. We also identified genes and pathways specific for FSGS versus MCD, and our data could help identify potential new biomarkers for the differential diagnosis between these two diseases.

Citing Articles

ECHS1 as a Lipid Metabolism Biomarker for Pediatric Focal Segmental Glomerulosclerosis.

He C, Peng W, Li S, Xu C, Chen X, Qin Y PLoS One. 2025; 20(3):e0319049.

PMID: 40063869 PMC: 11893130. DOI: 10.1371/journal.pone.0319049.


Adjustment of -value expression to ontology using machine learning for genetic prediction, prioritization, interaction, and its validation in glomerular disease.

Ettetuani B, Chahboune R, Moussa A Front Genet. 2023; 14:1215232.

PMID: 37900183 PMC: 10603191. DOI: 10.3389/fgene.2023.1215232.


Deconvolution of Focal Segmental Glomerulosclerosis Pathophysiology Using Transcriptomics Techniques.

Deleersnijder D, Van Craenenbroeck A, Sprangers B Glomerular Dis. 2023; 1(4):265-276.

PMID: 36751384 PMC: 9677714. DOI: 10.1159/000518404.


An Approach to Identify Therapeutic Target and Markers Associated with Diabetic Nephropathy.

Rai B, Maurya P, Srivastava M, Mishra P, Asif M, Tiwari S Curr Diabetes Rev. 2022; 21(2):e100622205872.

PMID: 35702773 DOI: 10.2174/1573399819666220610191935.


Glomerular Kidney Diseases in the Single-Cell Era.

Latt K, Heymann J, Yoshida T, Kopp J Front Med (Lausanne). 2021; 8:761996.

PMID: 34778322 PMC: 8585743. DOI: 10.3389/fmed.2021.761996.


References
1.
Xie J, Wu X, Ren H, Wang W, Wang Z, Pan X . COL4A3 mutations cause focal segmental glomerulosclerosis. J Mol Cell Biol. 2015; 6(6):498-505. DOI: 10.1093/jmcb/mju040. View

2.
Maric C, Zheng W, Walther T . Interactions between angiotensin ll and atrial natriuretic peptide in renomedullary interstitial cells: the role of neutral endopeptidase. Nephron Physiol. 2006; 103(3):p149-56. DOI: 10.1159/000092457. View

3.
Miyoshi K, Akazawa Y, Horiguchi T, Noma T . Localization of adenylate kinase 4 in mouse tissues. Acta Histochem Cytochem. 2009; 42(2):55-64. PMC: 2685024. DOI: 10.1267/ahc.08012. View

4.
Fan Y, Wei C, Xiao W, Zhang W, Wang N, Chuang P . Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression. PLoS One. 2014; 9(3):e93019. PMC: 3965528. DOI: 10.1371/journal.pone.0093019. View

5.
Pereira N, Aksoy P, Moon I, Peng Y, Redfield M, Burnett Jr J . Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation. J Mol Cell Cardiol. 2010; 49(5):864-74. PMC: 3092155. DOI: 10.1016/j.yjmcc.2010.07.020. View